This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Somatization disorder

Authoring team

Somatization disorder is a specific syndrome characterised by:

  • multiple somatic complaints
  • no organic pathology
  • no autonomic overstimulation
  • symptoms which have persisted for several years

Onset of a somatization disorder is usually before the age of 30. Thereafter it runs a chronic course with repeated recurrences of symptoms.

The syndrome is also referred to as multiple somatization disorder, St. Louis Hysteria and Briquet's syndrome.

The syndrome was named after Briquet by a group in St. Louis, USA. Briquet was a French physician who in 1859 wrote an influential monograph on hysteria.

Management

  • pharmacotherapy with serotonin-reuptake inhibitors appears to be effective for patients with the obsessional cluster of somatoform disorders (1)
  • cognitive behaviour therapy be of benefit in patients with somatization disorder (2)

Reference:

  1. Fallon BA. Pharmacotherapy of somatoform disorders. J Psychosom Res. 2004 Apr;56(4):455-60.
  2. Allen LA et al. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med. 2006 Jul 24;166(14):1512-8
  3. Kendell, R. E. Hysteria, somatization and the sick role. Medicine International. 1991;95: 3945.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.